Itolizumab to save many COVID 19 patients, asserts Biocon Ltd
After India’s drug regulator approved Itolizumab, for “restricted emergency use” to treat COVID-19 patients with moderate to severe acute respiratory […]
Say something
Friday
May
Upcoming Event
After India’s drug regulator approved Itolizumab, for “restricted emergency use” to treat COVID-19 patients with moderate to severe acute respiratory […]
Enter your email to receive a weekly round-up of our best posts.